Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Claudia P. Schroeder"'
Autor:
Richard L. Hengel, Claudia P. Schroeder, Jinhee Jo, Timothy E. Ritter, Ramesh V. Nathan, Anne J. Gonzales-Luna, Engels N. Obi, Ryan J. Dillon, Lucinda J. Van Anglen, Kevin W. Garey
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-6 (2022)
Abstract Background Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed cha
Externí odkaz:
https://doaj.org/article/07dc502960f347a0b814aa9c7e96e398
Publikováno v:
Open Forum Infectious Diseases. 10
Background Ceftolozane/tazobactam (C/T) is indicated for the treatment of complicated intra-abdominal infection (IAI), complicated urinary tract infection (UTI), and hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8496dc0fb312aa72f45a7a7322b0830
https://doi.org/10.1093/ofid/ofad173
https://doi.org/10.1093/ofid/ofad173
Autor:
Ramesh V Nathan, Brian S Metzger, Jorge R Bernett, John S Adams, Richard L Hengel, Rishi Bhattacharyya, Claudia P Schroeder, Kimberly A Couch, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Infections with extended-spectrum β-lactamase (ESBL)-producing pathogens present treatment challenges with higher costs of care. Hospitalized patients (pts) with ESBL infections often require outpatient antimicrobial therapy (OPAT) follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::991fbb2a6f2a71ef68acc6223b585b45
https://doi.org/10.1093/ofid/ofac492.726
https://doi.org/10.1093/ofid/ofac492.726
Publikováno v:
Open Forum Infectious Diseases. 9
Background Omadacycline (OMC) is approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Real-world data on the use of OMC are limited. We present a multicenter observational review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d70d675d26c9f29542aee6018b5255f7
https://doi.org/10.1093/ofid/ofac492.857
https://doi.org/10.1093/ofid/ofac492.857
Autor:
Clifford P Martin, Thomas K Sleweon, Quyen Luu, Richard C Prokesch, Robin H Dretler, Barry Statner, Kent J Stock, Claudia P Schroeder, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be safe and effective for self-administration but can lead to non-adherence without supervision. A physician office infusion center (POIC) with pharmacy services provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b478c034469d10c1fedd2702e2365b62
https://doi.org/10.1093/ofid/ofac492.847
https://doi.org/10.1093/ofid/ofac492.847
Publikováno v:
Open Forum Infectious Diseases. 9
Background AKI is a complication of intravenous vancomycin (VAN) occurring in up to 43% of patients (pts) during hospitalization. Data on AKI in pts receiving VAN through outpatient parenteral antimicrobial therapy (OPAT) are limited. There is sugges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58224c2c6768b01882caed40b4ffe76e
https://doi.org/10.1093/ofid/ofac492.662
https://doi.org/10.1093/ofid/ofac492.662
Autor:
Claudia P. Schroeder, Richard L. Hengel, Ramesh V. Nathan, Timothy E. Ritter, Engels N. Obi, Chris Lancaster, Lucinda J. Van Anglen, Kevin W. Garey
Publikováno v:
Anaerobe. 77
Patients with Clostridioides difficile infection (CDI) who receive treatment at outpatient infusion centers (OICs) pose a risk for spore transmission. We investigated C. difficile contamination in the environment of CDI and non-CDI patients and evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd10421aa808fd15c43f5197315d4a0f
https://pubmed.ncbi.nlm.nih.gov/35940371
https://pubmed.ncbi.nlm.nih.gov/35940371
Autor:
Richard L, Hengel, Claudia P, Schroeder, Jinhee, Jo, Timothy E, Ritter, Ramesh V, Nathan, Anne J, Gonzales-Luna, Engels N, Obi, Ryan J, Dillon, Lucinda J, Van Anglen, Kevin W, Garey
Publikováno v:
Journal of patient-reported outcomes. 6(1)
Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed changes in HrQOL over t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3d185287404b6b31fa0891a52795fa7
https://pubmed.ncbi.nlm.nih.gov/35567724
https://pubmed.ncbi.nlm.nih.gov/35567724
Autor:
Richard L Hengel, Stephen Marcella, Ryan J Dillon, Ramesh V Nathan, Lucinda J. Van Anglen, Kevin W. Garey, Timothy E. Ritter, Claudia P. Schroeder
Publikováno v:
Open Forum Infectious Diseases. 7
Background Bezlotoxumab is approved for prevention of recurrence of Clostridioides difficile infection (CDI) in adults receiving standard of care (SoC) therapy based on findings from MODIFY clinical trials. However, utilization practices and validati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f09d234f6dcdc066ec44ef7059419e5
https://doi.org/10.1093/ofid/ofaa097
https://doi.org/10.1093/ofid/ofaa097
Autor:
Richard L Hengel, Kimberly A Couch, David N Rhoads, Claudia P. Schroeder, John S. Adams, Quyen Luu, Rishi Bhattacharyya, Lucinda J. Van Anglen, Brian S Metzger
Publikováno v:
Open Forum Infectious Diseases
Background New vancomycin (VAN) guidelines have been published, with recommendations that dosing in patients (pts) with methicillin-resistant S. aureus (MRSA) infections be guided by VAN area under the concentration-time curve from 0 to 24 h to MIC r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee433a3dc0c1ad8080cb594a27a1f4c
https://doi.org/10.1093/ofid/ofaa439.1509
https://doi.org/10.1093/ofid/ofaa439.1509